Fenofibrate combined with Rosuvastatin

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Myalgia Other Serious 11/20/2006 61 Male 170 lb 11/20/2006 Pharmacist United States
Primary
Concomitant
Rhabdomyolysis Hospitalization 12/16/2006 39 Male 12/21/2006 Physician United States
Primary
Concomitant
High Density Lipoprotein Decreased Other Serious 54 Male 2/19/2007 Consumer United Kingdom
Primary
Secondary
Concomitant
Nephrotic Syndrome Required Intervention 1/22/2007 61 Male 3/13/2007 Consumer United States
Primary
Secondary
Urine Analysis Abnormal Hospitalization 67 Female 9/6/2007 United States
Primary
Secondary
Concomitant
Nausea 11/25/2007 Female 156 lb 12/15/2007 United States
Primary
Concomitant
Rhabdomyolysis Hospitalization Male 9/17/2007 India
Primary
Secondary
Blood Glucose Increased Other Serious Female 194 lb 1/22/2008 United States
Primary
Concomitant
Tinnitus Other Serious 8/1/2007 71 Female 176 lb 12/5/2007 Physician United States
Primary
Secondary
Concomitant
Residual Urine Hospitalization 5/1/2003 56 Male 168 lb 3/3/2008 Consumer United States
Primary
Secondary
Concomitant
Blood Glucose Increased Other Serious Female 198 lb 3/28/2008 United States
Primary
Concomitant
Stomach Discomfort 9/1/2007 Male 225 lb 5/12/2008 Consumer United States
Primary
Concomitant
Respiratory Distress Hospitalization 4/29/2008 Male 260 lb 5/27/2008 Physician United States
Primary
Concomitant
Pharyngeal Disorder 1/1/2006 Female 154 lb 8/22/2008 Physician United States
Primary
Concomitant
Coronary Arterial Stent Insertion Hospitalization 5/2/2008 Female 246 lb 9/12/2008 Other Health Professional
Primary
Concomitant
Weight Decreased 6/1/2008 Male 193 lb 9/13/2008 Consumer United States
Primary
Concomitant
Peripheral Vascular Disorder Other Serious 5/2/2008 Female 246 lb 9/23/2008 Physician United States
Primary
Concomitant
Medication Residue Female 11/17/2008 Physician Puerto Rico
Primary
Concomitant
Weight Decreased 6/1/2008 Male 193 lb 12/12/2008 Consumer United States
Primary
Concomitant
Chest Pain Hospitalization 11/28/2008 Male 12/12/2008 United States
Primary
Concomitant
Localised Infection 9/4/2008 Female 160 lb 12/12/2008 United States
Primary
Concomitant
Drug Ineffective Male 225 lb 12/12/2008 United States
Primary
Concomitant
Hyperhidrosis 6/1/2008 Female 156 lb 12/12/2008 United States
Primary
Concomitant
Rash 7/18/2008 Female 8/21/2009 United States
Primary
Concomitant
Pruritus Male 207 lb 8/21/2009 United States
Primary
Concomitant
Feeling Hot 6/25/2008 Male 235 lb 8/21/2009 Physician United States
Primary
Concomitant
Formication 7/7/2008 Male 8/21/2009 Other Health Professional United States
Primary
Concomitant
Rash Pruritic 7/22/2008 Male 8/21/2009 Other Health Professional United States
Primary
Concomitant
Flushing Female 8/21/2009 United States
Primary
Concomitant
Paraesthesia 7/1/2008 Male 8/21/2009 United States
Primary
Concomitant
Night Sweats 8/1/2008 Female 8/21/2009 United States
Primary
Concomitant
Insomnia Male 8/21/2009 United States
Primary
Concomitant
Pruritus 9/5/2008 Male 8/21/2009 United States
Primary
Concomitant
Flushing 1/1/2007 Female 8/22/2009 United States
Primary
Concomitant
Pruritus 10/13/2008 Male 8/22/2009
Primary
Concomitant
Flushing Female 8/22/2009 United States
Primary
Concomitant
Flushing 10/1/2008 Male 8/22/2009 United States
Primary
Concomitant
Nausea 11/1/2008 Male 8/22/2009 United States
Primary
Concomitant
Stress Hospitalization 61 Female 180 lb 9/28/2009 United States
Primary
Concomitant
Shigella Infection Death 1/1/2008 50 Male 3/25/2010 Physician United Kingdom
Primary
Secondary
Concomitant
Rhabdomyolysis Life Threatening 2/11/2010 64 Male 245 lb 3/29/2010 Pharmacist United States
Primary
Secondary
Shigella Infection Death 1/1/2008 50 Male 3/30/2010 Physician United Kingdom
Primary
Secondary
Concomitant
Myalgia Other Serious 72 Female 213 lb 4/21/2010 Consumer United Kingdom
Primary
Secondary
Concomitant
Myalgia Other Serious 72 Female 213 lb 5/4/2010 Consumer United Kingdom
Primary
Secondary
Concomitant
Myalgia Other Serious 72 Female 213 lb 5/27/2010 Consumer United Kingdom
Primary
Secondary
Concomitant
Musculoskeletal Pain 5/28/2010 Consumer United States
Primary
Secondary
Concomitant
Myalgia Other Serious 72 Female 213 lb 6/17/2010 Consumer United Kingdom
Primary
Secondary
Concomitant
Lung Adenocarcinoma Stage Iv Hospitalization 5/1/2010 57 Female 143 lb 6/18/2010 Other Health Professional United States
Primary
Concomitant
Hypoglycaemia Other Serious 58 Male 6/15/2010 Pharmacist United States
Primary
Secondary
Concomitant
Liver Function Test Abnormal Other Serious 71 Male 176 lb 6/24/2010 Other Health Professional Australia
Primary
Secondary
Concomitant
Erythema Multiforme Other Serious 5/14/2010 68 Female 6/29/2010 Other Health Professional Germany
Primary
Concomitant
Hypoglycaemia Other Serious 58 Male 6/28/2010 Other Health Professional United States
Primary
Secondary
Concomitant
Liver Function Test Abnormal Other Serious 71 Male 176 lb 7/1/2010 Other Health Professional Australia
Primary
Secondary
Concomitant
Hypoglycaemia Other Serious 58 Male 7/7/2010 Other Health Professional United States
Primary
Concomitant
Interacting
Lung Adenocarcinoma Stage Iv Hospitalization 5/1/2010 57 Female 143 lb 8/18/2010 Other Health Professional United States
Primary
Concomitant
Lung Adenocarcinoma Stage Iv Hospitalization 5/7/2010 57 Female 143 lb 11/17/2010 Other Health Professional United States
Primary
Concomitant
Lung Adenocarcinoma Stage Iv Hospitalization 5/19/2010 57 Female 143 lb 12/6/2010 Other Health Professional United States
Primary
Concomitant
Lung Adenocarcinoma Stage Iv Hospitalization 5/6/2010 57 Female 143 lb 1/20/2011 Other Health Professional United States
Primary
Concomitant
Injection Site Haemorrhage 9/25/2010 74 Male 1/30/2011 Consumer United States
Primary
Concomitant
Blood Creatine Phosphokinase Increased Hospitalization 12/1/2010 52 Male 2/4/2011 Physician United States
Primary
Secondary
Concomitant
Blood Potassium Decreased Hospitalization 12/1/2010 52 Male 3/4/2011 Consumer United States
Primary
Secondary
Concomitant
Intentional Drug Misuse Hospitalization 1/1/2009 62 Male 210 lb 3/11/2011 Consumer United States
Primary
Secondary
Concomitant
Blood Potassium Decreased Hospitalization 12/1/2010 52 Male 3/28/2011 Consumer United States
Primary
Secondary
Concomitant
Dizziness Hospitalization 3/18/2011 70 Female 156 lb 3/29/2011 Consumer United States
Primary
Concomitant
Anticonvulsant Drug Level Above Therapeutic Hospitalization 64 Female 4/25/2011 United States
Primary
Concomitant
High Density Lipoprotein Decreased Other Serious 54 Male 6/1/2011 Other Health Professional United Kingdom
Primary
Concomitant
Interacting
Hypoaesthesia Hospitalization 1/10/2011 48 Male 6/10/2011 Other Health Professional Australia
Primary
Concomitant
Apolipoprotein A-i Decreased Other Serious 56 Female 6/10/2011 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
High Density Lipoprotein Decreased Other Serious 56 Female 6/21/2011 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
High Density Lipoprotein Decreased Other Serious 1/1/2005 56 Female 6/27/2011 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
High Density Lipoprotein Decreased Other Serious 54 Male 6/28/2011 Consumer United Kingdom
Primary
Secondary
Concomitant
Apolipoprotein A-i Decreased Other Serious 56 Female 6/27/2011 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Apolipoprotein A-i Decreased Other Serious 6/30/2011 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Blood Potassium Decreased Hospitalization 12/1/2010 52 Male 7/6/2011 Other Health Professional United States
Primary
Secondary
Concomitant
High Density Lipoprotein Decreased Other Serious 56 Female 7/7/2011 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Apolipoprotein A-i Decreased Other Serious 1/1/2005 56 Female 7/8/2011 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
High Density Lipoprotein Decreased Other Serious 56 Female 6/28/2011 Other Health Professional
Primary
Secondary
Concomitant
Apolipoprotein Decreased Other Serious 56 Female 7/6/2011 Physician
Primary
Secondary
Concomitant
Mental Status Changes Hospitalization 4/21/2011 65 Male 236 lb 7/20/2011 Physician United States
Primary
Concomitant
High Density Lipoprotein Decreased Other Serious 56 Female 7/22/2011 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Metabolic Syndrome Other Serious 56 Female 7/14/2011 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
High Density Lipoprotein Decreased Other Serious 56 Female 7/22/2011 Physician
Primary
Secondary
Concomitant
Psychotic Disorder Hospitalization 6/27/2011 50 Male 7/29/2011 Physician Australia
Primary
Concomitant
Implantable Defibrillator Insertion Hospitalization 12/1/2010 67 Male 231 lb 8/4/2011 Physician United States
Primary
Concomitant
Hypotension Hospitalization 4/21/2011 65 Male 236 lb 8/4/2011 Physician United States
Primary
Concomitant
Pruritus 74 Male 8/5/2011 Consumer United States
Primary
Concomitant
Blood Potassium Decreased Hospitalization 12/1/2010 52 Male 8/12/2011 Other Health Professional United States
Primary
Secondary
Concomitant
Psychotic Disorder Hospitalization 6/27/2011 50 Male 8/16/2011 Physician Australia
Primary
Concomitant
Tremor Hospitalization 6/6/2011 48 Male 8/31/2011 Other Health Professional Australia
Primary
Concomitant
Cardiac Disorder Other Serious 12/29/2009 79 Male 9/14/2011 Physician France
Primary
Concomitant
Fatigue 1/1/2005 63 Male 9/26/2011 Consumer United States
Primary
Secondary
Concomitant
Orthostatic Hypotension Hospitalization 4/21/2011 65 Male 236 lb 10/17/2011 Physician United States
Primary
Concomitant
Rectal Haemorrhage Hospitalization 10/13/2011 72 Male 201 lb 11/28/2011 Physician United Kingdom
Primary
Concomitant
Abdominal Pain Upper Hospitalization 1/13/2012 65 Male 241 lb 1/31/2012 Physician Australia
Primary
Secondary
Concomitant
Abdominal Pain Upper Hospitalization 1/13/2012 65 Male 247 lb 1/31/2012 Physician Australia
Primary
Secondary
Concomitant
Blood Lactate Dehydrogenase Increased Hospitalization 73 Female 2/14/2012 Other Health Professional Spain
Primary
Concomitant
Interacting
Abdominal Pain Hospitalization 1/13/2012 65 Male 241 lb 2/17/2012 Physician Australia
Primary
Secondary
Concomitant
Drug Interaction Hospitalization 73 Female 2/22/2012 Other Health Professional Spain
Primary
Concomitant
Interacting
Drug Interaction Death 73 Female 2/22/2012 Other Health Professional Spain
Primary
Concomitant
Interacting
Drug Interaction Hospitalization 73 Female 2/22/2012 Other Health Professional Spain
Primary
Concomitant
Interacting
Rhabdomyolysis Hospitalization 73 Female 2/24/2012 Other Health Professional Spain
Primary
Concomitant
Interacting
Rhabdomyolysis Other Serious 73 Female 2/28/2012 Other Health Professional Spain
Primary
Concomitant
Interacting
Urinary Retention Hospitalization 2/19/2012 63 Male 258 lb 3/5/2012 United Kingdom
Primary
Concomitant
Rhabdomyolysis Other Serious 73 2/29/2012 Other Health Professional Spain
Primary
Secondary
Concomitant
Abdominal Pain Upper Hospitalization 1/13/2012 65 Male 241 lb 3/13/2012 Physician Australia
Primary
Secondary
Concomitant
Drug Interaction Death 73 Female 3/15/2012 Other Health Professional Spain
Primary
Concomitant
Interacting
Drug Interaction Death 73 Female 3/16/2012 Other Health Professional Spain
Primary
Concomitant
Interacting
Anaemia Required Intervention 1/1/2010 58 Male 3/21/2012 Other Health Professional United Kingdom
Primary
Concomitant
Renal Failure Acute Hospitalization 12/30/2011 63 Male 258 lb 4/3/2012 Physician United Kingdom
Primary
Concomitant
Benign Breast Neoplasm Other Serious 3/26/2012 46 Female 179 lb 4/10/2012 Physician United Kingdom
Primary
Concomitant
Blood Potassium Decreased Hospitalization 12/1/2010 52 Male 4/11/2012 Other Health Professional United States
Primary
Secondary
Concomitant
Chest Pain Hospitalization 12/30/2011 63 Male 258 lb 4/19/2012 United Kingdom
Primary
Concomitant
Vomiting Other Serious 2/23/2012 60 Female 132 lb 4/20/2012 Physician United Kingdom
Primary
Concomitant
Confusional State Other Serious 12/30/2011 63 Male 258 lb 4/25/2012 United Kingdom
Primary
Concomitant
Nightmare Other Serious 33 Male 5/23/2012 Other Health Professional Turkey
Primary
Secondary
Gait Disturbance Other Serious 1/1/2011 78 Male 165 lb 5/25/2012 Consumer Brazil
Primary
Secondary
Concomitant
Impulse-control Disorder Other Serious 33 Male 5/28/2012 Other Health Professional Turkey
Primary
Secondary
Concomitant
Amnesia Other Serious 33 Male 6/5/2012 Other Health Professional Turkey
Primary
Secondary
Migraine Other Serious 11/1/2011 52 Female 200 lb 5/24/2012 Physician United States
Primary
Concomitant
Ventilation Perfusion Mismatch Death 5/24/2012 64 Male 6/7/2012 Other Health Professional United States
Primary
Concomitant
Ventilation Perfusion Mismatch Death 5/24/2012 64 Male 6/26/2012 Other Health Professional United States
Primary
Concomitant
Diarrhoea Hospitalization 9/1/2011 46 Female 397 lb 7/2/2012 Physician United States
Primary
Secondary
Concomitant
Syncope Hospitalization 6/27/2012 62 Female 200 lb 7/12/2012 Physician United States
Primary
Concomitant
Syncope Hospitalization 6/27/2012 62 Female 200 lb 7/18/2012 Physician United States
Primary
Concomitant
Malaise Other Serious Male 8/3/2012 Consumer United Kingdom
Primary
Secondary
Concomitant
Myalgia Other Serious 7/10/2008 34 Female 8/7/2012 Consumer United Kingdom
Primary
Secondary
Concomitant
Chromaturia Other Serious 7/10/2008 34 Female 8/13/2012 Physician United Kingdom
Primary
Secondary
Concomitant
Groin Pain Other Serious 7/10/2008 34 Female 8/16/2012 Consumer United Kingdom
Primary
Secondary
Concomitant
Groin Pain Other Serious 7/10/2008 34 Female 8/16/2012 Consumer United Kingdom
Primary
Secondary
Concomitant
Myalgia Other Serious 7/10/2008 34 Female 8/6/2012 United Kingdom
Primary
Secondary
Concomitant
Thirst Other Serious 7/10/2008 34 Female 8/20/2012 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Myalgia Other Serious 7/10/2008 34 Female 8/20/2012 Consumer United Kingdom
Primary
Secondary
Concomitant
Groin Pain Other Serious 7/10/2008 34 Female 8/24/2012 Consumer United Kingdom
Primary
Secondary
Concomitant
Embolic Stroke Hospitalization 59 Male 7/19/2012 Lawyer Us
Primary
Concomitant
Syncope Hospitalization 6/27/2012 62 Female 200 lb 11/15/2012 Physician Us
Primary
Concomitant
Syncope Hospitalization 6/27/2012 62 Female 200 lb 11/20/2012 Physician Us
Primary
Concomitant
Coronary Artery Occlusion Hospitalization 6/29/2012 62 Male 168 lb 9/17/2012 Other Health Professional Ca
Primary
Concomitant
Eosinophil Count Increased Other Serious 9/18/2012 38 Male 12/10/2012 Physician Ie
Primary
Concomitant
Sleep Disorder Other Serious 2005 78 Male 183 lb 11/26/2013 Consumer Gb
Primary
Secondary
Sleep Disorder Other Serious 2005 78 Male 183 lb 11/27/2013 Consumer Gb
Primary
Secondary
Sleep Disorder Other Serious 2005 78 Male 183 lb 4/3/2013 Consumer Gb
Primary
Secondary
Sleep Disorder Other Serious 2005 78 Male 183 lb 4/5/2013 Consumer Gb
Primary
Secondary
Sleep Disorder Other Serious 2005 78 Male 183 lb 4/5/2013 Consumer Gb
Primary
Secondary
Malaise Other Serious 58 Male 4/15/2013 Other Health Professional Us
Primary
Secondary
Concomitant
Wrong Technique In Drug Usage Process Other Serious 2/2013 54 Female 6/6/2013 Consumer Us
Primary
Concomitant
Rhabdomyolysis Hospitalization 4/13/2013 78 Male 181 lb 5/23/2013 Pharmacist Us
Primary
Secondary
Cholecystitis Hospitalization 6/7/2013 81 Male 6/21/2013 Pharmacist Us
Primary
Concomitant
White Blood Cell Count Decreased Disability 12/16/2011 60 Male 238 lb 6/24/2013 Physician Ca
Primary
Secondary
Concomitant
Death Death Male 214 lb 8/26/2013 Consumer Ca
Primary
Concomitant
Melaena Hospitalization 8/19/2013 78 Male 192 lb 8/23/2013 Pharmacist Us
Primary
Concomitant

Drug Data